Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Licensing opportunity from NIH: method of inhibiting Hsp90 with novobiocin

Aug. 3, 1999

Ontogen completes phase I bioavailability study of MDR-modulating compound

Aug. 3, 1999

Solimastat is a potent MMP inhibitor with significant advantages over related compounds

Aug. 2, 1999

New apoptosis inducers claimed by Takara Shuzo

Aug. 2, 1999

Anti-VEGF enhances efficacy of radiation therapy

Aug. 2, 1999

NuOncology Labs awarded U.S. patent for anticancer compounds

Aug. 2, 1999

Pharmacokinetic and efficacy studies reported for novel prostate cancer drug

Aug. 2, 1999

Bavarian Nordic to begin phase II study of pancreatic cancer therapy

July 30, 1999

Pilot trial commences for Eligix's BCell-HDM product

July 30, 1999

Disaccharide ester with anti-TNF-alpha effects and chemopreventive efficacy

July 29, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...